SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals & Industries informs about board meeting

19 May 2017 Evaluate

Krebs Biochemicals & Industries has informed that the meeting of Board of Directors of the Company is scheduled to be held on Friday, 26th May 2017 to consider and approve the audited financial results along with the auditor’s report for the year ended 31st March, 2017; Any other matter with the permission of the Chair. Further, in connection to the above, trading window for dealing in shares of the Company will remain closed for the specified persons as defined in the Code from 19th May, 2017 and shall re-open 48 hours after the publication of the results to the public.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

60.90 -0.12 (-0.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×